Skip to main content
. 2013 Jun 24;123(7):3135–3145. doi: 10.1172/JCI67544

Figure 2. CONSORT diagram for this phase I nonrandomized clinical trial.

Figure 2

14 eligible subjects underwent leukapheresis to generate the DC vaccine. 12 subjects were immunized with their autologous vaccine, while 2 subjects who developed CNS metastases (an exclusion criterion) were not vaccinated, and their participation in the trial was discontinued. All 12 vaccinated subjects underwent complete follow-up and analysis.